-
Cancer Apr 2019
Topics: Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Carboplatin; Clinical Decision-Making; Disease Progression; Etoposide; Humans; Immunoconjugates; Irinotecan; Liver Neoplasms; Lung Neoplasms; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Nivolumab; Paclitaxel; Piperazines; Pyrimidines; Salvage Therapy; Small Cell Lung Carcinoma; Temozolomide; Thiourea; Topotecan
PubMed: 30561759
DOI: 10.1002/cncr.31849 -
Gynecologic Oncology Jun 2021A 73-year-old woman with metastatic vaginal mucosal melanoma that had progressed on ipilimumab and nivolumab experienced clinical and radiographic complete response to...
A 73-year-old woman with metastatic vaginal mucosal melanoma that had progressed on ipilimumab and nivolumab experienced clinical and radiographic complete response to dual checkpoint inhibitor immunotherapy given in combination with high-dose plus low-dose radiation. General characteristics and treatment options in this disease are highlighted.
Topics: Aged; Antineoplastic Agents, Immunological; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Ipilimumab; Melanoma; Mucous Membrane; Neoplasm Metastasis; Nivolumab; Radiotherapy; Urethral Neoplasms; Vaginal Neoplasms
PubMed: 33795130
DOI: 10.1016/j.ygyno.2021.03.017